UBS Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.3M | Buy |
|
|||||
|
2025
Q2 | $25.8M | Buy |
|
|||||
|
2025
Q1 | $16M | Buy |
|
|||||
|
2024
Q4 | $22.6M | Buy |
|
|||||
|
2024
Q3 | $9.56M | Sell |
|
|||||
|
2024
Q2 | $11.9M | Buy |
|
|||||
|
2024
Q1 | $1.44M | Buy |
|
|||||
|
2023
Q4 | $922K | Sell |
|
|||||
|
2023
Q3 | $682K | Sell |
|
|||||
|
2023
Q2 | $3.2M | Buy |
|
|||||
|
2023
Q1 | $2.78M | Buy |
|
|||||
|
2022
Q4 | $1.69M | Sell |
|
|||||
|
2022
Q3 | $3.11M | Sell |
|
|||||
|
2022
Q2 | $6.66M | Sell |
|
|||||
|
2022
Q1 | $36.8M | Sell |
|
|||||
|
2021
Q4 | $60.9M | Buy |
|
|||||
|
2021
Q3 | $34M | Buy |
|
|||||
|
2021
Q2 | $26.6M | Sell |
|
|||||
|
2021
Q1 | $32.6M | Buy |
|
|||||
|
2020
Q4 | $24.8M | Buy |
|
|||||
|
2020
Q3 | $12.5M | Buy |
|
|||||
|
2020
Q2 | $10.8M | Sell |
|
|||||
|
2020
Q1 | $7.69M | Buy |
|
|||||
|
2019
Q4 | $6.49M | Buy |
|
|||||
|
2019
Q3 | $3.12M | Buy |
|
|||||
|
2019
Q2 | $1.94M | Sell |
|
|||||
|
2019
Q1 | $1.97M | Buy |
|
|||||
|
2018
Q4 | $951K | Sell |
|
|||||
|
2018
Q3 | $3.34M | Buy |
|
|||||
|
2018
Q2 | $190K | Buy |
|
|||||
|
2018
Q1 | $1K | Sell |
|
|||||
|
2017
Q4 | $90K | Buy |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $11K | Buy |
|
|||||
|
2017
Q1 | $1K | Sell |
|
|||||
|
2016
Q4 | $6K | Buy |
|
|||||
|
2016
Q3 | $0 | Sell |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $7K | Sell |
|
|||||
|
2015
Q4 | $19K | Buy |
|
|||||
|
2015
Q3 | $3K | Buy |
|
|||||
|
2015
Q2 | $0 | Sell |
|
|||||
|
2015
Q1 | $23K | Buy |
|
|||||
|
2014
Q4 | $2K | Buy |
|